Kolb Disease (Paget‑Schroetter Syndrome)
Overview
Paget‑Schroetter syndrome (PSS), also called **effort‑related thrombosis of the subclavian vein** or **Kolb disease**, is a form of deep‑vein thrombosis (DVT) that occurs in the upper extremity, most often at the junction of the subclavian and brachiocephalic veins. The clot forms after strenuous or repetitive activity of the arm and shoulder—think rowing, weight‑lifting, or gymnastics.
Although upper‑extremity DVT accounts for only ~1–4 % of all DVT cases, PSS represents the majority of these effort‑related cases. It most commonly affects:
- Young, otherwise healthy adults (median age 30–35 y)
- Men more often than women (≈ 3:1 ratio)
- Athletes and individuals with occupations that involve repetitive overhead arm motions (e.g., weight‑lifters, baseball pitchers, construction workers).
Because the condition is rare and often misdiagnosed, many patients experience weeks of pain before a correct diagnosis is made.
Symptoms
Symptoms develop abruptly during or shortly after intense arm activity and may progress over days to weeks. Common manifestations include:
- Pain or aching in the neck, shoulder, or upper arm—usually on the dominant side.
- Swelling (edema) of the entire arm, sometimes extending to the hand and forearm.
- Visible veins (collateral veins) across the chest wall or shoulder—often described as “spider veins.”
- Heaviness or a feeling of fullness in the arm, making it difficult to lift objects.
- Coldness or discoloration of the hand if venous return is severely compromised.
- Reduced range of motion due to pain and swelling.
- Fever, chills, or malaise—less common, may indicate a secondary infection.
Because symptoms mimic musculoskeletal injuries, a high index of suspicion is needed, especially in athletes or individuals with recent repetitive overhead activities.
Causes and Risk Factors
Underlying Pathophysiology
PSS is primarily a **mechanical compression** of the subclavian vein as it passes between the first rib and the clavicle (the costoclavicular space). Repetitive arm elevation or hyperabduction narrows this space, causing endothelial injury, turbulence, and ultimately thrombosis.
Risk Factors
- Intense, repetitive upper‑extremity activity: rowing, swimming, weight‑training, baseball pitching, tennis, or manual labor.
- Anatomical variants: a cervical rib, clavicular malposition, or a narrow costoclavicular space increase compression.
- Hypercoagulable states: factor V Leiden, prothrombin G20210A mutation, antiphospholipid syndrome, elevated homocysteine, or use of oral contraceptives.
- Trauma or central venous catheter placement in the subclavian vein (though this more often causes catheter‑related thrombosis).
- Obesity and smoking—these contribute to a pro‑thrombotic environment.
- Male gender and age 20‑40 y—likely reflects higher participation in high‑intensity sports.
Diagnosis
Early recognition is essential to prevent long‑term complications such as post‑thrombotic syndrome. Diagnosis combines a detailed history, physical exam, and imaging.
Clinical Evaluation
- History of recent vigorous arm activity.
- Inspection for swelling, cyanosis, and dilated superficial veins.
- Palpation for tenderness over the subclavian‑brachiocephalic junction.
- Assessment for neurovascular compromise (e.g., diminished pulse, paresthesias).
Imaging & Laboratory Tests
- Doppler Ultrasound (Duplex): First‑line, bedside test detecting flow obstruction, thrombus, and collateral veins. Sensitivity ≈ 78 % and specificity ≈ 97 % for upper‑extremity DVT.
- Contrast‑enhanced CT venography (CTV): Provides detailed anatomy of the thoracic outlet, identifies compressive bony anomalies, and visualizes clot extent.
- MR Venography (MRV): Useful when radiation exposure is a concern; offers high‑resolution images of soft tissue and vascular structures.
- Venography (conventional): Gold standard but invasive; reserved for cases where non‑invasive tests are equivocal or when endovascular treatment is planned.
- Laboratory work‑up: Complete blood count, coagulation profile (PT/INR, aPTT), D‑dimer (often elevated but non‑specific), and thrombophilia screen if a hereditary clotting disorder is suspected.
Treatment Options
Management aims to (1) dissolve or remove the clot, (2) relieve mechanical compression, and (3) prevent recurrence.
1. Anticoagulation
- Initial therapy: Low‑molecular‑weight heparin (LMWH) or unfractionated heparin intravenously for 5‑7 days.
- Long‑term anticoagulation: Direct oral anticoagulants (DOACs) such as apixaban or rivaroxaban are now preferred for 3‑6 months, per CDC guidelines.
- Anticoagulation alone does not address the underlying venous compression, so additional interventions are usually required.
2. Thrombolysis & Mechanical Thrombectomy
- Catheter‑directed thrombolysis (CDT): Infusion of tissue‑type plasminogen activator (tPA) directly into the clot for 12‑24 hours. Best outcomes when performed within 14 days of symptom onset.
- Pharmacomechanical thrombectomy: Combines low‑dose thrombolytic agents with mechanical devices (e.g., AngioJet) to accelerate clot removal.
- Both techniques improve vein patency and reduce post‑thrombotic symptoms, but carry bleeding risk (≈ 5‑10 %).
3. Surgical Decompression – First‑Rib Resection (Thoracic Outlet Decompression)
- Performed after acute clot management, usually within 2‑6 weeks.
- Involves removal of the first rib (and sometimes part of the cervical rib) to enlarge the costoclavicular space, releasing the subclavian vein.
- Success rates > 90 % for symptom resolution and low recurrence when combined with anticoagulation.
- Potential complications: nerve injury, pneumothorax, or postoperative hematoma.
4. Stenting (Selective)
- Reserved for residual venous stenosis after adequate decompression.
- Self‑expanding nitinol stents have shown good mid‑term patency but are used cautiously because of the risk of fracture in the mobile thoracic outlet.
5. Lifestyle & Supportive Measures
- Elevation of the affected arm and use of compression sleeves (20–30 mmHg) to reduce edema.
- Pain control with acetaminophen or NSAIDs (if no contraindication).
- Physical therapy after surgical decompression to restore range of motion and strengthen scapular stabilizers.
- Gradual return to activity—often 6‑12 weeks post‑surgery under physician guidance.
Living with Kolb Disease (Paget‑Schroetter Syndrome)
Even after successful treatment, patients may need to adopt habits that protect vein health and minimize recurrence.
- Gradual progression of activity: Increase training intensity by no more than 10 % per week.
- Avoid prolonged overhead positions: Take micro‑breaks every 30 minutes during weight‑lifting or computer work.
- Maintain a healthy weight: Obesity adds pressure on the thoracic outlet.
- Stay hydrated: Adequate fluid intake helps maintain blood viscosity.
- Regular follow‑up imaging: Duplex ultrasound at 3 months, 6 months, and then annually for the first 2 years.
- Medication adherence: Complete the prescribed anticoagulation course; never stop a DOAC without physician approval.
- Awareness of symptoms: Promptly report new swelling, pain, or discoloration to your clinician.
Prevention
Because the primary trigger is mechanical compression, prevention focuses on ergonomics and fitness balance.
- Technique training: Work with a qualified coach or physical therapist to ensure proper form in sports that involve overhead motions.
- Strengthen scapular stabilizers: Exercises such as rows, external rotations, and scapular squeezes improve posture and reduce rib‑clavicle compression.
- Warm‑up and stretch: Dynamic shoulder warm‑ups before heavy lifting decrease sudden strain.
- Periodic screening: Athletes with recurrent upper‑extremity swelling should undergo duplex ultrasound to detect early venous changes.
- Avoid smoking and limit alcohol: Both increase clotting propensity.
- Consider prophylactic anticoagulation only in rare cases of known severe thrombophilia and under specialist supervision.
Complications
If left untreated or inadequately managed, PSS can lead to serious sequelae:
- Post‑thrombotic syndrome (PTS): Chronic swelling, pain, and skin changes that impair arm function.
- Recurrent thrombosis: Up to 30 % recurrence without surgical decompression.
- Pulmonary embolism (PE): Although less common than with lower‑extremity DVT, PE can occur—estimate of 5‑10 % in untreated cases.
- Venous hypertension: May cause collateral vein formation and visible “corkscrew” veins on the chest.
- Neurovascular injury: Persistent compression can affect the brachial plexus, leading to numbness or weakness.
When to Seek Emergency Care
Warning signs that require immediate medical attention:
- Sudden, severe swelling of the arm accompanied by intense pain.
- Chest pain, shortness of breath, or rapid heartbeat—possible pulmonary embolism.
- Cold, pale, or bluish discoloration of the hand or fingers.
- Loss of sensation or weakness in the arm or hand.
- Fever > 38 °C (100.4 °F) with worsening pain—suggests infection.
Call 911 or go to the nearest emergency department if any of these symptoms develop.
References
- Mayo Clinic. “Upper extremity deep vein thrombosis (UEDVT).” https://www.mayoclinic.org. Accessed June 2026.
- CDC. “Deep Vein Thrombosis (DVT) Treatment.” https://www.cdc.gov. Updated 2023.
- NIH National Heart, Lung, and Blood Institute. “Paget‑Schroetter Syndrome.” https://www.nhlbi.nih.gov. 2022.
- Cleveland Clinic. “Upper‑Extremity DVT (Paget‑Schroetter) – Diagnosis and Management.” https://my.clevelandclinic.org. 2024.
- Jaffer, A. et al. “Catheter‑directed thrombolysis for effort‑related subclavian vein thrombosis.” *J Vasc Surg* 2021;73(4):1245‑1252.
- Schwartz, L.R., “Thoracic outlet syndrome and Paget‑Schroetter syndrome.” *Ann Surg* 2020;271(5):904‑915.